CoChat

Stimulant Medications and Attention Deficit–Hyperactivity Disorder

Open access
Cohen, Adam L., Jhung, Michael A., Budnitz, Daniel S. · 2006 · New England Journal of Medicine
Cited by 34

The DOI matches its Crossref record.

Abstract

To the Editor: On February 9, 2006, a Food and Drug Administration (FDA) advisory panel recommended that stimulant drugs prescribed for attention deficit–hyperactivity disorder (ADHD) carry warnings about the potential for an increased risk of sudden death and cardiovascular problems such as hypertension, cardiac arrest, arrhythmias, and stroke.1 Although stimulant drugs are known to cause adverse cardiovascular effects,2,3 little is known about the incidence and type of adverse events in the community setting. To explore this issue, we examined adverse events from stimulant medications prescribed for the treatment of ADHD. We used data from the National Electronic Injury Surveillance . . .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmc060860

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 34

Metadata

Authors
Cohen, A. L., Jhung, M. A., & Budnitz, D. S.
Venue
New England Journal of Medicine
Published
2006-05-25
Volume
354
Issue
21
Pages
2294-2295
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1973082463
Cited by
34
References
0
FWCI
2.49
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Stimulant Medications and Attention Deficit–Hyperactivity Disorder. https://app.cochat.ai/papers/10.1056/nejmc060860
The paper
Cohen, A. L., Jhung, M. A., & Budnitz, D. S. (2006). Stimulant Medications and Attention Deficit–Hyperactivity Disorder. New England Journal of Medicine. https://doi.org/10.1056/nejmc060860

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.